$2.41 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 73 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | $121,713,000 | -1.7% | 240,997 | 0.0% | 5.05% | +7.4% | |
| OTIS | OTIS WORLDWIDE CORP | $82,779,000 | -9.7% | 1,297,480 | 0.0% | 3.44% | -1.4% | |
| ALVOTECHordinary shares | $6,760,000 | -17.7% | 1,000,000 | 0.0% | 0.28% | -9.9% | ||
| GMTX | GEMINI THERAPEUTICS INC | $3,891,000 | -2.9% | 2,372,267 | 0.0% | 0.16% | +6.6% | |
| MOLN | MOLECULAR PARTNERS AGads | $2,676,000 | -1.3% | 400,000 | 0.0% | 0.11% | +7.8% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $2,136,000 | +4.1% | 4,059,894 | 0.0% | 0.09% | +14.1% | |
| SIOX | SIO GENE THERAPIES INC | $1,656,000 | -22.3% | 5,914,000 | 0.0% | 0.07% | -14.8% | |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $1,611,000 | -59.2% | 1,491,832 | 0.0% | 0.07% | -55.3% | |
| OTIC | OTONOMY INC | $928,000 | -85.8% | 3,144,196 | 0.0% | 0.04% | -84.3% | |
| FLAC | FRAZIER LIFESCIENCES ACQU CO | $872,000 | +0.9% | 87,498 | 0.0% | 0.04% | +9.1% | |
| BNTC | BENITEC BIOPHARMA INC | $286,000 | -67.9% | 769,000 | 0.0% | 0.01% | -64.7% | |
| TMPMW | TURMERIC ACQUISITION CORP*w exp 10/08/202 | $1,000 | -75.0% | 52,775 | 0.0% | 0.00% | – | |
| OPY ACQUISITION CORP I*w exp 09/22/202 | $8,000 | -55.6% | 72,605 | 0.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ADOBE SYSTEMS INCORPORATED | 33 | Q4 2021 | 13.2% |
| CONSTELLATION BRANDS INC | 20 | Q4 2018 | 10.9% |
| AMAZON COM INC | 20 | Q3 2023 | 8.0% |
| UNITEDHEALTH GROUP INC | 20 | Q3 2023 | 5.7% |
| IQVIA HLDGS INC | 19 | Q3 2023 | 7.3% |
| RESTAURANT BRANDS INTL INC | 18 | Q3 2019 | 8.9% |
| UNION PAC CORP | 17 | Q2 2023 | 5.1% |
| META PLATFORMS INC | 16 | Q3 2023 | 10.9% |
| COPART INC | 15 | Q4 2021 | 2.3% |
| SUTRO BIOPHARMA INC | 15 | Q3 2023 | 1.9% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Zura Bio Ltd | June 15, 2023 | 2,850,000 | 6.6% |
| InflaRx N.V. | April 24, 2023 | 5,733,910 | 10.3% |
| Benitec Biopharma Inc. | April 18, 2023 | 3,020,214 | 10.0% |
| Aeglea BioTherapeutics, Inc. | February 13, 2023 | 6,376,373 | 10.0% |
| Bolt Biotherapeutics, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| Cano Health, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| CHIMERIX INCSold out | February 13, 2023 | 0 | 0.0% |
| Disc Medicine, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| OTONOMY, INC.Sold out | February 13, 2023 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 13, 2023 | 0 | 0.0% |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-05-02 |
| SC 13D | 2024-04-29 |
| SC 13G | 2024-04-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.